Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study

Abhijeet Anand, Damaris Jepkosgei, Christina Mwachari, Rose Jalang'o, Lynn Kitwan, Cyrus Kagecha, Ian Leboo, Abubakar Hussein, Boniface Kitungulu, Hudson Kigen, Pius Mutuku, Farrell A. Tobolowsky, Basit Jafri, Daniel Lang'at, Bernardo A. Mainou, Eric Wiesen, Sam Wafula, Qian An, Jamal Ahmed, Amy Herman-Roloff, Emily Koech

Open source

DOI: 10.1016/j.vaccine.2026.128969
Published: 2026-10
Container: Vaccine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128969,
  title = {Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study},
  author = {Abhijeet Anand and Damaris Jepkosgei and Christina Mwachari and Rose Jalang'o and Lynn Kitwan and Cyrus Kagecha and Ian Leboo and Abubakar Hussein and Boniface Kitungulu and Hudson Kigen and Pius Mutuku and Farrell A. Tobolowsky and Basit Jafri and Daniel Lang'at and Bernardo A. Mainou and Eric Wiesen and Sam Wafula and Qian An and Jamal Ahmed and Amy Herman-Roloff and Emily Koech},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128969},
  url = {https://doi.org/10.1016/j.vaccine.2026.128969}
}

RIS

TY  - JOUR
TI  - Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study
AU  - Abhijeet Anand
AU  - Damaris Jepkosgei
AU  - Christina Mwachari
AU  - Rose Jalang'o
AU  - Lynn Kitwan
AU  - Cyrus Kagecha
AU  - Ian Leboo
AU  - Abubakar Hussein
AU  - Boniface Kitungulu
AU  - Hudson Kigen
AU  - Pius Mutuku
AU  - Farrell A. Tobolowsky
AU  - Basit Jafri
AU  - Daniel Lang'at
AU  - Bernardo A. Mainou
AU  - Eric Wiesen
AU  - Sam Wafula
AU  - Qian An
AU  - Jamal Ahmed
AU  - Amy Herman-Roloff
AU  - Emily Koech
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128969
UR  - https://doi.org/10.1016/j.vaccine.2026.128969
ER  -

APA

Anand, A., Jepkosgei, D., Mwachari, C., Jalang'o, R., Kitwan, L., Kagecha, C., Leboo, I., Hussein, A., Kitungulu, B., Kigen, H., Mutuku, P., Tobolowsky, F. A., Jafri, B., Lang'at, D., Mainou, B. A., Wiesen, E., Wafula, S., An, Q., Ahmed, J., Herman-Roloff, A., & Koech, E. (2026). Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128969

Source records

crossref · retrieved 2026-11-07T22:03:05.821Z